News
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics
For the quarter ended September 2025, 10x Genomics (TXG) reported revenue of $149 million, down 1.8% over the same period last year. EPS came in at -$0.22, compared to -$0.30 in the year-ago
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.59 per share a year ago. These
Chemours (CC) Reports Q3 Earnings: What Key Metrics Have to Say
Chemours (CC) reported $1.5 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 0.4%. EPS of $0.20 for the same period compares to $0.40 a year ago.
The
Inseego (INSG) Lags Q3 Earnings Estimates
Inseego (INSG) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to a loss of $0.07 per share a year ago. These figures are
Topgolf Callaway (MODG) Reports Q3 Earnings: What Key Metrics Have to Say
Topgolf Callaway Brands (MODG) reported $934 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 7.8%. EPS of -$0.05 for the same period compares to
CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates
CytomX Therapeutics (CTMX) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.07 per share a year ago. These
Compared to Estimates, Doximity (DOCS) Q2 Earnings: A Look at Key Metrics
Doximity (DOCS) reported $168.53 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 23.2%. EPS of $0.45 for the same period compares to $0.30 a year
Figs (FIGS) Reports Q3 Earnings: What Key Metrics Have to Say
Figs (FIGS) reported $151.66 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 8.2%. EPS of $0.05 for the same period compares to -$0.01 a year ago.
Compared to Estimates, BILL Holdings (BILL) Q1 Earnings: A Look at Key Metrics
For the quarter ended September 2025, BILL Holdings (BILL) reported revenue of $395.74 million, up 10.4% over the same period last year. EPS came in at $0.61, compared to $0.63 in the year-ago
Huntsman (HUN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2025, Huntsman (HUN) reported revenue of $1.46 billion, down 5.2% over the same period last year. EPS came in at -$0.03, compared to $0.10 in the year-ago quarter.
Alta Equipment (ALTG) Reports Q3 Loss, Misses Revenue Estimates
Alta Equipment (ALTG) came out with a quarterly loss of $1.31 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.86 per share a year ago. These figures
Compared to Estimates, Peloton (PTON) Q1 Earnings: A Look at Key Metrics
For the quarter ended September 2025, Peloton (PTON) reported revenue of $550.8 million, down 6% over the same period last year. EPS came in at $0.03, compared to $0 in the year-ago quarter.
The
Barings BDC (BBDC) Beats Q3 Earnings and Revenue Estimates
Barings BDC (BBDC) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.29 per share a year ago. These
Zacks November View on Equity Markets
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of
Should the Hype for First Solar (FLSR) Stock Continue?
Printing a fresh all-time high of $281 a share this week, First Solar FSLR stock regained bullish momentum after its Q3 report last Thursday.
The 20% rally over the last month has added to pleasant
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.22 per share a year ago. These
indie Semiconductor, Inc. (INDI) Reports Q3 Loss, Misses Revenue Estimates
indie Semiconductor, Inc. (INDI) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.09 per share a year ago
Globalstar (GSAT) Reports Q3 Loss, Tops Revenue Estimates
Globalstar (GSAT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to break-even earnings per share a year ago. These figures
Cherry Hill Mortgage (CHMI) Q3 Earnings Miss Estimates
Cherry Hill Mortgage (CHMI) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.08 per share a year ago
Globus Medical (GMED) Tops Q3 Earnings and Revenue Estimates
Globus Medical (GMED) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.83 per share a year ago. These
Concentra Group (CON) Q3 Earnings and Revenues Top Estimates
Concentra Group (CON) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.37 per share a year ago. These
Certara, Inc. (CERT) Q3 Earnings Surpass Estimates
Certara, Inc. (CERT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.13 per share a year ago. These
November Asset Allocation Guidelines
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of
ZRS Chart of the Month
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of
NuScale Power Corporation (SMR) Reports Q3 Loss, Lags Revenue Estimates
NuScale Power Corporation (SMR) came out with a quarterly loss of $1.85 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.18 per share a year ago. These


